Interstitial Lung Disease and Lung Cancer Development: A 5-Year Nationwide Population-Based Study
Won-Il Choi, Sun Hyo Park, Byeong Ju Park, Choong Won Lee
Cancer Res Treat. 2018;50(2):374-381.   Published online 2017 May 8     DOI: https://doi.org/10.4143/crt.2017.119
Citations to this article as recorded by Crossref logo
The impact of air pollution on interstitial lung disease: a systematic review and meta-analysis
Doris Lan, Caitlin C. Fermoyle, Lauren K. Troy, Luke D. Knibbs, Tamera J. Corte
Frontiers in Medicine.2024;[Epub]     CrossRef
Subsolid Nodules
Lea Azour, Andrea S. Oh, Ashley E. Prosper, Danielle Toussie, Geraldine Villasana-Gomez, Lila Pourzand
Clinics in Chest Medicine.2024;[Epub]     CrossRef
Clinical characteristics and outcome of lung cancer in patients with fibrosing interstitial lung disease
Soo Jin Han, Hyeon Hwa Kim, Dong-gon Hyun, Wonjun Ji, Chang-Min Choi, Jae Cheol Lee, Ho Cheol Kim
BMC Pulmonary Medicine.2024;[Epub]     CrossRef
Effects of Light-absorbing Carbons in Intraoperative Molecular Imaging–Guided Lung Cancer Resections
Feredun Azari, Gregory Kennedy, Kevin Zhang, Elizabeth Bernstein, Ashley Chang, Bilal Nadeem, Alix Segil, Charuhas Desphande, James Delikatny, John Kucharczuk, Sunil Singhal
Molecular Imaging and Biology.2023; 25(1): 156.     CrossRef
Management of Lung Cancer in the Patient with Interstitial Lung Disease
Angela J Frank, Ibiayi Dagogo-Jack, Ioana A Dobre, Sarah Tait, Lana Schumacher, Florian J Fintelmann, Leah M Fingerman, Florence K Keane, Sydney B Montesi
The Oncologist.2023; 28(1): 12.     CrossRef
Is pulmonary fibrosis a precancerous disease?
Mahdie Hosseini, Mary Salvatore
European Journal of Radiology.2023; 160: 110723.     CrossRef
Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
Jang Ho Lee, Hyung Jun Park, Seonok Kim, Ye-Jee Kim, Ho Cheol Kim
BMC Pulmonary Medicine.2023;[Epub]     CrossRef
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review
Anna Stainer, Antonio Tonutti, Maria De Santis, Francesco Amati, Angela Ceribelli, Gabriele Bongiovanni, Chiara Torrisi, Antonio Iacopino, Giuseppe Mangiameli, Stefano Aliberti, Carlo Selmi
Frontiers in Medicine.2023;[Epub]     CrossRef
KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway
Junmei Guo, Wei Zhang, Liping Sun, Hongfang Yu, Yuzhe Wang, Li Feng, Hao Yang
Scientific Reports.2023;[Epub]     CrossRef
Proteomic analysis of serum in workers exposed to diesel engine exhaust
Mohammad L. Rahman, Bryan A. Bassig, Yufei Dai, Wei Hu, Jason Y. Y. Wong, Batel Blechter, H. Dean Hosgood, Danzhi Ren, Huawei Duan, Yong Niu, Jun Xu, Wei Fu, Kees Meliefste, Baosen Zhou, Jufang Yang, Meng Ye, Xiaowei Jia, Tao Meng, Ping Bin, Debra T. Silv
Environmental and Molecular Mutagenesis.2022; 63(1): 18.     CrossRef
Two-Stage Hybrid Approach of Deep Learning Networks for Interstitial Lung Disease Classification
Swati P. Pawar, Sanjay N. Talbar, Fan Yang
BioMed Research International.2022; 2022: 1.     CrossRef
Improvement in Stage of Lung Cancer Diagnosis With Incidental Pulmonary Nodules Followed With a Patient Tracking System and Computerized Registry
Laurie L. Carr, Debra S. Dyer, Pearlanne T. Zelarney, Elizabeth O. Kern
JTO Clinical and Research Reports.2022; 3(3): 100297.     CrossRef
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells, Manuela Funke-Chambour
ERJ Open Research.2022; 8(2): 00115-2022.     CrossRef
Comorbidity and life expectancy in shared decision making for lung cancer screening
Brett Bade, Mary Gwin, Matthew Triplette, Renda Soylemez Wiener, Kristina Crothers
Seminars in Oncology.2022; 49(3-4): 220.     CrossRef
Inhaled Corticosteroids and the Risk of Lung Cancer in Chronic Obstructive Pulmonary Disease Patients: A Systematic Review and Meta-Analysis
Amare Abera Tareke, Wondwosen Debebe, Addis Alem, Nebiyou Simegnew Bayileyegn, Taddese Alemu Zerfu, Andualem Mossie Ayana, Kazuyoshi Kuwano
Pulmonary Medicine.2022; 2022: 1.     CrossRef
MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer (Review)
Xindi Liang, Qiang Wu, Yuan Wang, Shirong Li
Oncology Reports.2022;[Epub]     CrossRef
Idiopathic pulmonary fibrosis and lung cancer: future directions and challenges
Ahmad Abu Qubo, Jamil Numan, Juan Snijder, Maria Padilla, John H.M. Austin, Kathleen M. Capaccione, Monica Pernia, Jean Bustamante, Timothy O'Connor, Mary M. Salvatore
Breathe.2022; 18(4): 220147.     CrossRef
Shades of Gray
Lea Azour, Jane P. Ko, David P. Naidich, William H. Moore
Chest.2021; 159(5): 2072.     CrossRef
Prevalence, incidence and cause-specific mortality of rheumatoid arthritis–associated interstitial lung disease among older rheumatoid arthritis patients
Jeffrey A Sparks, Yinzhu Jin, Soo-Kyung Cho, Seanna Vine, Rishi Desai, Tracy J Doyle, Seoyoung C Kim
Rheumatology.2021; 60(8): 3689.     CrossRef
Diagnosis and Management of Fibrotic Interstitial Lung Diseases
Bridget F. Collins, Fabrizio Luppi
Clinics in Chest Medicine.2021; 42(2): 321.     CrossRef
Idiopathic Pulmonary Comorbidities and Mechanisms
Maricica Pacurari, Amal Mitra, Timothy Turner, Jian-Dong Li
International Journal of Inflammation.2021; 2021: 1.     CrossRef
Repurposing Anticancer Drugs for the Treatment of Idiopathic Pulmonary Fibrosis and Antifibrotic Drugs for the Treatment of Cancer: State of the Art
Panagiotis Paliogiannis, Sara Solveig Fois, Alessandro Giuseppe Fois, Antonio Cossu, Giuseppe Palmieri, Gianfranco Pintus
Current Medicinal Chemistry.2021; 28(11): 2234.     CrossRef
Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?
George E Fragoulis, Katerina Chatzidionysiou
Clinical Rheumatology.2020; 39(3): 957.     CrossRef
Pharmacological treatment of pulmonary fibrosis
Won-Il Choi
Journal of the Korean Medical Association.2020; 63(1): 47.     CrossRef
Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review
Paolo Cameli, Elena Bargagli, Laura Bergantini, Miriana d’Alessandro, Maria Pieroni, Giovanni A. Fontana, Piersante Sestini, Rosa Metella Refini
International Journal of Molecular Sciences.2020; 21(17): 6187.     CrossRef
Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study
Won-Il Choi, Dong Yoon Lee, Hyun-Gi Choi, Choong Won Lee
Respiratory Research.2019;[Epub]     CrossRef
Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease
Osamu Kanai, Young Hak Kim, Yoshiki Demura, Makiko Kanai, Tsuyoshi Ito, Kohei Fujita, Hironori Yoshida, Masaya Akai, Tadashi Mio, Toyohiro Hirai
Thoracic Cancer.2018; 9(7): 847.     CrossRef
Germline mutations in young non-smoking women with lung adenocarcinoma
Iikki Donner, Riku Katainen, Lauri J. Sipilä, Mervi Aavikko, Eero Pukkala, Lauri A. Aaltonen
Lung Cancer.2018; 122: 76.     CrossRef
Risk factors for interstitial lung disease: a 9-year Nationwide population-based study
Won-Il Choi, Sonila Dauti, Hyun Jung Kim, Sun Hyo Park, Jae Seok Park, Choong Won Lee
BMC Pulmonary Medicine.2018;[Epub]     CrossRef
Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy
Fangjuan Li, Ziyang Zhou, Ailu Wu, Yong Cai, Hongyu Wu, Ming Chen, Shixiong Liang
Radiation Oncology.2018;[Epub]     CrossRef